Satish Reddy Kunnam

Title: Innovations of Satish Reddy Kunnam

Introduction

Satish Reddy Kunnam is a notable inventor based in Warangal, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit dihydroorotate oxygenase (DHODH). With a total of three patents to his name, Kunnam's work is paving the way for new cancer treatments.

Latest Patents

Kunnam's latest patents focus on trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors. The first patent describes methods for treating cancer in a subject and inhibiting tumor growth, metastasis, or dihydroorotate oxygenase enzyme activity in tumor or cancer cells. The invention involves administering at least one trisubstituted benzotriazole derivative with a specific formula to the subject or contacting it with the cancer cell. The compounds have substituents that are defined in the specification, along with their pharmaceutically acceptable salts. The second patent also provides trisubstituted benzotriazole derivatives as DHODH inhibitor compounds, which may be therapeutically useful in treating diseases where inhibiting DHODH is advantageous. Additionally, this patent outlines methods for synthesizing these derivatives and includes pharmaceutical formulations comprising the DHODH inhibitor compounds along with acceptable carriers, diluents, or excipients.

Career Highlights

Throughout his career, Kunnam has worked with various companies, including Aurigene Discovery Technologies Limited and Um Pharmauji Sdn. Bhd. His experience in these organizations has contributed to his expertise in pharmaceutical research and development.

Collaborations

Kunnam has collaborated with notable colleagues such as Siva Sanjeeva Rao Thunuguntla and Subramanya Hosahalli. These collaborations have likely enhanced his research capabilities and broadened the impact of his inventions.

Conclusion

Satish Reddy Kunnam's innovative work in the field of pharmaceuticals, particularly in cancer treatment, showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective therapies that could significantly benefit patients in need.